Vita Coco CCO sells 2,000 shares in plan trade

Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock at $57.98 per share on March 16, 2026.

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock at $57.98 per share on March 16, 2026. The filing notes these sales were effected under a Rule 10b5-1 trading plan.

After the transaction, van Es directly holds 79,691 shares of common stock. He also holds several non-qualified stock options to buy additional Vita Coco shares, including grants exercisable at $10.178 per share expiring on February 10, 2030 and January 11, 2031, and higher-priced options expiring through March 4, 2035.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares

Net Sell 9 txns

Insider van Es Charles

Role Chief Commercial Officer

Sold 2,000 shs ($116K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,000	$57.98	$116K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 79,691 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 232,267 contracts (Direct)

Footnotes (8)

1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. F2. The stock option is fully vested and currently exercisable.
3. F3. The stock option vests in four equal annual installments beginning on November 27, 2022.
4. F4. The stock option vests in three equal annual installments beginning on August 15, 2025.
5. F5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
6. F6. The stock options vest in four annual equal installments beginning on March 10, 2024.
7. F7. The stock option vests in four equal annual installments beginning on March 4, 2025.
8. F8. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vita Coco (COCO) report for Charles van Es?

Vita Coco’s Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 common shares. The shares were sold at $57.98 each on March 16, 2026, according to a Form 4 insider trading disclosure filed with regulators.

How many Vita Coco (COCO) shares did Charles van Es sell and at what price?

Charles van Es sold 2,000 Vita Coco common shares at $57.98 per share. This single open-market transaction on March 16, 2026, was reported on Form 4 and classified as a routine sale rather than part of an option exercise sequence.

How many Vita Coco (COCO) shares does Charles van Es hold after the reported sale?

After selling 2,000 shares, Charles van Es directly holds 79,691 Vita Coco common shares. This remaining position, disclosed in the Form 4 filing, shows he retains a substantial equity stake in the company following the relatively small open-market sale.

Was the Vita Coco (COCO) insider sale by Charles van Es made under a Rule 10b5-1 plan?

Yes. A footnote states the sales of Vita Coco common stock were effected under a Rule 10b5-1 trading plan. Such plans are pre-arranged trading programs that schedule transactions in advance, helping separate routine diversification from discretionary market-timing decisions.

What stock options in Vita Coco (COCO) does Charles van Es hold according to the filing?

The filing shows multiple non-qualified stock options on Vita Coco common stock held by Charles van Es. These include options exercisable at $10.178, $15.00, $15.36, $16.91, $26.18, and $33.36 per share, with expiration dates running from 2030 through 2035.

Did Charles van Es exercise any Vita Coco (COCO) stock options in this Form 4?

No option exercises are reported in this Form 4; only an open-market sale of 2,000 common shares appears. The derivative section lists his existing stock option holdings and vesting details but does not show transactions coded as option exercises on March 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van Es Charles

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		S(1)		2,000	D	$57.98	79,691	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	02/10/2030	Common Stock	53,750		53,750	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	01/11/2031	Common Stock	27,300		27,300	D
Non-Qualified Stock Option (Right to Buy)	$15							(3)	10/21/2031	Common Stock	58,043		58,043	D
Non-Qualified Stock Option (Right to Buy)	$15.36							(4)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(5)	03/10/2033	Common Stock	14,025		14,025	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(6)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(7)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (Right to Buy)	$33.36							(8)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option is fully vested and currently exercisable.

3. The stock option vests in four equal annual installments beginning on November 27, 2022.

4. The stock option vests in three equal annual installments beginning on August 15, 2025.

5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.

6. The stock options vest in four annual equal installments beginning on March 10, 2024.

7. The stock option vests in four equal annual installments beginning on March 4, 2025.

8. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	/s/ Alison Klein, attorney-in-fact for Charles van Es	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)